Therapeutic compositions consisting of clarified multi-filtered soluable sodium silicate in liquid form are found to modify suppressor cells and enhanse the human immune system toprevent recurrence of herpes infections
CA 2298762 C · Owner: Pidcock, Paul M. · Inventors: Pidcock, Paul M.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
This discovery and invention relates to a therapeutic composition of matter which may be used for the home treatment of herpes-caused cutaneous infections whereby the formation of new lesions is prevented. The preferred composition comprises a liquid which is a clarified multi-filtered soluble sodium silicate in which the minerals are suspended in an aqueous solution. Application to the infection is found to modify the suppressor cells and such enhanses the immune system. This new therapy is a remarkable improvement to the present art for treatment of Herpes viruses as the disease symptoms disappear permanently while existing treatments only reduce the severity of the disease. Up to this …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed February 11, 2000 and granted June 12, 2001. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended February 11, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by February 11, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.